BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• A Personal Letter to the Shareholders From TapImmune’s New Chief Executive Officer

  TapImmune announces a letter from the CEO.

  October 18, 2017

   · 

  7 min read
• Business

  Dr. Jan Van De Winkel Joins Hookipa As Chairman Of Its Board Of Directors

  Hookipa Biotech, a company pioneering an innovative class of immunotherapies for oncology and infectious diseases, today announced the appointment of Dr. Jan van de Winkel as Chairman of its Board of Directors.

  October 18, 2017

   · 

  4 min read
• Policy

  FDA Accepts Regulatory Submission for AstraZeneca’s LYNPARZA (Olaparib) in Metastatic Breast Cancer and Grants Priority Review

  LYNPARZA has the potential to offer a new treatment option for patients with germline BRCA-mutated, HER2-negative metastatic breast cancer.

  October 18, 2017

   · 

  13 min read
• Biotech Bay

  Episona Enters Consumer Market with Epigenetics Test for Male Infertility

  Episona announced today that it is entering the consumer market with the first at-home, epigenetics-based test for evaluating male infertility.

  October 18, 2017

   · 

  4 min read
• Pharm Country

  Novartis Drug Promacta Shows Long-Term Disease Control For Chronic/Persistent Immune Thrombocytopenia

  Novartis today announced long-term study results supporting the positive safety and efficacy of Promacta (eltrombopag) in adults with chronic/persistent immune (idiopathic) thrombocytopenia (ITP).

  October 18, 2017

   · 

  15 min read
• U.S. Patent Granted For Benitec Hepatitis B Program

  Benitec is pleased to announce that a new patent relating to the Company’s hepatitis B program has been issued in the United States.

  October 18, 2017

   · 

  3 min read
• Biotech Beach

  Trovagene’s PLK1 Inhibitor (PCM-075) Demonstrates Synergy with Zytiga® (abiraterone acetate) in Castration Resistant Prostate Cancer Tumor Cells

  Trovagene today announced positive data from preclinical research demonstrating synergy of PCM-075, its oral, highly-selective Polo-like Kinase 1 (PLK1) Inhibitor, in combination with abiraterone (Zytiga - J&J)/

  October 18, 2017

   · 

  7 min read
• Genetown

  Respiratory Motion is Excited to Announce the Launch of the Latest ExSpiron 1Xi Respiratory Monitor

  Respiratory Motion announced today its plans to launch the newest version of its ExSpiron 1Xi Minute Ventilation (MV) Monitor at the ASA in Boston, October 21-25 following recent FDA clearance.

  October 18, 2017

   · 

  3 min read
• Aytu BioScience Announces Uplisting to The NASDAQ Capital Market

  Aytu BioScience today announced that its shares of common stock were approved for listing on The NASDAQ Capital Market.

  October 18, 2017

   · 

  4 min read
• Biotech Bay

  Blade Therapeutics Announces Selection Of A Clinical Development Candidate And Funding Of The Second Tranche For Its Series B Financing

  Blade Therapeutics announced that it has nominated a clinical development candidate for its lead program focused on small molecule inhibitors that selectively target certain intracellular cysteine proteases.

  October 18, 2017

   · 

  2 min read